Login / Signup

The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial.

Judith E HeidaRon T GansevoortVicente E TorresOlivier DevuystVicente E TorresJennifer LeeHui LiJohn OuyangArlene B Chapman
Published in: Journal of the American Society of Nephrology : JASN (2021)
TEMPO 3:4, NCT00428948.
Keyphrases
  • polycystic kidney disease
  • phase iii
  • study protocol
  • clinical trial
  • phase ii
  • randomized controlled trial
  • open label